Difference between revisions of "Event:1060"

From AOP-Wiki
Jump to: navigation, search
(Page created.)
 
(thomashill3 updated summary tables from widget page.)
 
(One intermediate revision by the same user not shown)
Line 5: Line 5:
  
 
== Key Event Overview ==
 
== Key Event Overview ==
Please follow link to [//{{SERVERNAME}}/events/{{PAGENAMEE}} widget page] to edit this section. <span style="color:#FF0000">'''If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.'''</span>
+
Please follow link to [//{{SERVERNAME}}/events/{{PAGENAMEE}} widget page] to edit this section.
 +
 
 +
<span style="color:#FF0000">'''If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.'''</span>
  
 
=== AOPs Including This Key Event ===
 
=== AOPs Including This Key Event ===
Line 16: Line 18:
 
!Event Type
 
!Event Type
 
!Essentiality
 
!Essentiality
 +
 +
|-
 +
 +
|[[Aop:166|PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse]]||KE||[[Aop:166#Essentiality of the Key Events|Weak]]
  
 
|-
 
|-

Latest revision as of 22:19, 26 July 2016


Event Title

lipid metabolism, Alteration

Key Event Overview

Please follow link to widget page to edit this section.

If you manually enter text in this section, it will get automatically altered or deleted in subsequent edits using the widgets.

AOPs Including This Key Event

AOP Name Event Type Essentiality
PPARalpha activation leading to pancreatic acinar tumors in the rat and mouse KE Weak

Taxonomic Applicability

Name Scientific Name Evidence Links

Level of Biological Organization

Biological Organization

How this Key Event works

How it is Measured or Detected

Methods that have been previously reviewed and approved by a recognized authority should be included in the Overview section above. All other methods, including those well established in the published literature, should be described here. Consider the following criteria when describing each method: 1. Is the assay fit for purpose? 2. Is the assay directly or indirectly (i.e. a surrogate) related to a key event relevant to the final adverse effect in question? 3. Is the assay repeatable? 4. Is the assay reproducible?

Evidence Supporting Taxonomic Applicability

References